aluates Reports

$ 0.0

Automative

Global Emerging Infectious Disease Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-37J14399

Global Emerging Infectious Disease Market Research Report 2023

BUY CHAPTERS

Global Emerging Infectious Disease Market Research Report 2025

Code: QYRE-Auto-37J14399

Report

May 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Biomerieux

Danaher

Orasure

Qiagen NV

Quidel

Sysmex

Gen-Probe

Cepheid Inc

Hologic Inc

Roche Diagnostics

Merck& Co. Inc

GlaxoSmithKline PLC

Emerging Infectious Disease Market Size

The global market for Emerging Infectious Disease was valued at US$ 21660 million in the year 2024 and is projected to reach a revised size of US$ 32180 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Emerging Infectious Disease Market

Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.

The global emerging infectious disease market refers to the market for diagnostics, treatments, and preventive measures for newly discovered or re-emerging infectious diseases. Emerging infectious diseases are those that have recently appeared in a population or have existed but are rapidly increasing in incidence or geographic range. These diseases pose a significant public health threat and require innovative approaches for detection, management, and control.

Here are some key factors influencing the growth of the global emerging infectious disease market:

Outbreaks and epidemics: The occurrence of outbreaks and epidemics of emerging infectious diseases, such as Ebola, Zika virus, and COVID-19, has created a heightened global awareness of the need for robust diagnostic tools, therapeutics, and preventive measures. These outbreaks drive the demand for rapid and accurate diagnostics to identify the causative agents, along with effective treatments and preventive strategies to control the spread of the diseases.

Technological advancements: Advances in diagnostic technologies, including nucleic acid amplification techniques, immunoassays, and point-of-care diagnostics, have significantly improved the speed and accuracy of diagnosing emerging infectious diseases. Additionally, the development of new antiviral drugs, vaccines, and other therapeutics has expanded treatment options for these diseases. The integration of technologies such as artificial intelligence, genomics, and big data analytics further enhances the capabilities of the healthcare system in managing emerging infectious diseases.

Government initiatives and funding: Governments and international organizations have recognized the need to invest in research and development, surveillance systems, and infrastructure to effectively respond to emerging infectious diseases. Increased funding and initiatives aimed at strengthening healthcare systems, surveillance networks, and research collaborations drive innovations in diagnostics, therapeutics, and preventive measures.

Global travel and urbanization: Increased global travel and urbanization contribute to the spread and emergence of infectious diseases. The movement of people across borders allows infections to spread rapidly, making it crucial to have effective measures in place for detection, containment, and treatment. This drives the demand for improved diagnostics, therapeutics, and public health strategies targeting emerging infectious diseases.

Antimicrobial resistance: The rise of antimicrobial resistance poses a significant challenge in the management of emerging infectious diseases. The limited effectiveness of existing antibiotics and antiviral drugs necessitates the development of new treatment options, including novel antibiotics, combination therapies, and innovative strategies that target the resistance mechanisms of pathogens.

The global emerging infectious disease market can be segmented based on disease type, diagnostic methods, treatment modalities, and geography. Disease types may include viral, bacterial, parasitic, and others. Diagnostic methods can include molecular diagnostics, immunoassays, and rapid diagnostic tests. Treatment modalities may include antiviral drugs, antibiotics, vaccines, and supportive care.

Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The prevalence of different emerging infectious diseases, healthcare infrastructure, and government initiatives may vary across these regions.

In summary, the global emerging infectious disease market is driven by outbreaks and epidemics, technological advancements, government initiatives, global travel, and antimicrobial resistance. Key players in the market are focused on developing innovative solutions for diagnostics, treatments, and preventive measures. The market is expected to witness significant growth as the need for effective management of emerging infectious diseases continues to rise globally.

This report aims to provide a comprehensive presentation of the global market for Emerging Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emerging Infectious Disease.

The Emerging Infectious Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Emerging Infectious Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Emerging Infectious Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Emerging Infectious Disease Market Report

Report Metric	Details
Report Name	Emerging Infectious Disease Market
Accounted market size in year	US$ 21660 million
Forecasted market size in 2031	US$ 32180 million
CAGR	5.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	AIDS Ebola SARS Avian Flu Chikungunya Zika Others
Segment by Application	Clinical Laboratories Diagnostic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, Abbott, Roche Diagnostics, Merck & Co., Inc., GlaxoSmithKline plc, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex, Gen-Probe, Cepheid, Hologic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emerging Infectious Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Emerging Infectious Disease Market growing?

Ans: The Emerging Infectious Disease Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Emerging Infectious Disease Market size in 2031?

Ans: The Emerging Infectious Disease Market size in 2031 will be US$ 32180 million.

Who are the main players in the Emerging Infectious Disease Market report?

Ans: The main players in the Emerging Infectious Disease Market are BD, Abbott, Roche Diagnostics, Merck & Co., Inc., GlaxoSmithKline plc, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex, Gen-Probe, Cepheid, Hologic

What are the Application segmentation covered in the Emerging Infectious Disease Market report?

Ans: The Applications covered in the Emerging Infectious Disease Market report are Clinical Laboratories, Diagnostic Centers, Others

What are the Type segmentation covered in the Emerging Infectious Disease Market report?

Ans: The Types covered in the Emerging Infectious Disease Market report are AIDS, Ebola, SARS, Avian Flu, Chikungunya, Zika, Others

Recommended Reports

Human Infectious Diseases

Veterinary Infectious Diagnostics

Virus and Bacterial Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Emerging Infectious Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 AIDS

1.2.3 Ebola

1.2.4 SARS

1.2.5 Avian Flu

1.2.6 Chikungunya

1.2.7 Zika

1.2.8 Others

1.3 Market by Application

1.3.1 Global Emerging Infectious Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinical Laboratories

1.3.3 Diagnostic Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Emerging Infectious Disease Market Perspective (2020-2031)

2.2 Global Emerging Infectious Disease Growth Trends by Region

2.2.1 Global Emerging Infectious Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Emerging Infectious Disease Historic Market Size by Region (2020-2025)

2.2.3 Emerging Infectious Disease Forecasted Market Size by Region (2026-2031)

2.3 Emerging Infectious Disease Market Dynamics

2.3.1 Emerging Infectious Disease Industry Trends

2.3.2 Emerging Infectious Disease Market Drivers

2.3.3 Emerging Infectious Disease Market Challenges

2.3.4 Emerging Infectious Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Emerging Infectious Disease Players by Revenue

3.1.1 Global Top Emerging Infectious Disease Players by Revenue (2020-2025)

3.1.2 Global Emerging Infectious Disease Revenue Market Share by Players (2020-2025)

3.2 Global Emerging Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Emerging Infectious Disease Revenue

3.4 Global Emerging Infectious Disease Market Concentration Ratio

3.4.1 Global Emerging Infectious Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Emerging Infectious Disease Revenue in 2024

3.5 Global Key Players of Emerging Infectious Disease Head office and Area Served

3.6 Global Key Players of Emerging Infectious Disease, Product and Application

3.7 Global Key Players of Emerging Infectious Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Emerging Infectious Disease Breakdown Data by Type

4.1 Global Emerging Infectious Disease Historic Market Size by Type (2020-2025)

4.2 Global Emerging Infectious Disease Forecasted Market Size by Type (2026-2031)

5 Emerging Infectious Disease Breakdown Data by Application

5.1 Global Emerging Infectious Disease Historic Market Size by Application (2020-2025)

5.2 Global Emerging Infectious Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Emerging Infectious Disease Market Size (2020-2031)

6.2 North America Emerging Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Emerging Infectious Disease Market Size by Country (2020-2025)

6.4 North America Emerging Infectious Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Emerging Infectious Disease Market Size (2020-2031)

7.2 Europe Emerging Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Emerging Infectious Disease Market Size by Country (2020-2025)

7.4 Europe Emerging Infectious Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Emerging Infectious Disease Market Size (2020-2031)

8.2 Asia-Pacific Emerging Infectious Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Emerging Infectious Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific Emerging Infectious Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Emerging Infectious Disease Market Size (2020-2031)

9.2 Latin America Emerging Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Emerging Infectious Disease Market Size by Country (2020-2025)

9.4 Latin America Emerging Infectious Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Emerging Infectious Disease Market Size (2020-2031)

10.2 Middle East & Africa Emerging Infectious Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Emerging Infectious Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa Emerging Infectious Disease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Details

11.1.2 BD Business Overview

11.1.3 BD Emerging Infectious Disease Introduction

11.1.4 BD Revenue in Emerging Infectious Disease Business (2020-2025)

11.1.5 BD Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Emerging Infectious Disease Introduction

11.2.4 Abbott Revenue in Emerging Infectious Disease Business (2020-2025)

11.2.5 Abbott Recent Development

11.3 Roche Diagnostics

11.3.1 Roche Diagnostics Company Details

11.3.2 Roche Diagnostics Business Overview

11.3.3 Roche Diagnostics Emerging Infectious Disease Introduction

11.3.4 Roche Diagnostics Revenue in Emerging Infectious Disease Business (2020-2025)

11.3.5 Roche Diagnostics Recent Development

11.4 Merck & Co., Inc.

11.4.1 Merck & Co., Inc. Company Details

11.4.2 Merck & Co., Inc. Business Overview

11.4.3 Merck & Co., Inc. Emerging Infectious Disease Introduction

11.4.4 Merck & Co., Inc. Revenue in Emerging Infectious Disease Business (2020-2025)

11.4.5 Merck & Co., Inc. Recent Development

11.5 GlaxoSmithKline plc

11.5.1 GlaxoSmithKline plc Company Details

11.5.2 GlaxoSmithKline plc Business Overview

11.5.3 GlaxoSmithKline plc Emerging Infectious Disease Introduction

11.5.4 GlaxoSmithKline plc Revenue in Emerging Infectious Disease Business (2020-2025)

11.5.5 GlaxoSmithKline plc Recent Development

11.6 BioMerieux

11.6.1 BioMerieux Company Details

11.6.2 BioMerieux Business Overview

11.6.3 BioMerieux Emerging Infectious Disease Introduction

11.6.4 BioMerieux Revenue in Emerging Infectious Disease Business (2020-2025)

11.6.5 BioMerieux Recent Development

11.7 Danaher

11.7.1 Danaher Company Details

11.7.2 Danaher Business Overview

11.7.3 Danaher Emerging Infectious Disease Introduction

11.7.4 Danaher Revenue in Emerging Infectious Disease Business (2020-2025)

11.7.5 Danaher Recent Development

11.8 Orasure

11.8.1 Orasure Company Details

11.8.2 Orasure Business Overview

11.8.3 Orasure Emerging Infectious Disease Introduction

11.8.4 Orasure Revenue in Emerging Infectious Disease Business (2020-2025)

11.8.5 Orasure Recent Development

11.9 Qiagen

11.9.1 Qiagen Company Details

11.9.2 Qiagen Business Overview

11.9.3 Qiagen Emerging Infectious Disease Introduction

11.9.4 Qiagen Revenue in Emerging Infectious Disease Business (2020-2025)

11.9.5 Qiagen Recent Development

11.10 Quidel

11.10.1 Quidel Company Details

11.10.2 Quidel Business Overview

11.10.3 Quidel Emerging Infectious Disease Introduction

11.10.4 Quidel Revenue in Emerging Infectious Disease Business (2020-2025)

11.10.5 Quidel Recent Development

11.11 Sysmex

11.11.1 Sysmex Company Details

11.11.2 Sysmex Business Overview

11.11.3 Sysmex Emerging Infectious Disease Introduction

11.11.4 Sysmex Revenue in Emerging Infectious Disease Business (2020-2025)

11.11.5 Sysmex Recent Development

11.12 Gen-Probe

11.12.1 Gen-Probe Company Details

11.12.2 Gen-Probe Business Overview

11.12.3 Gen-Probe Emerging Infectious Disease Introduction

11.12.4 Gen-Probe Revenue in Emerging Infectious Disease Business (2020-2025)

11.12.5 Gen-Probe Recent Development

11.13 Cepheid

11.13.1 Cepheid Company Details

11.13.2 Cepheid Business Overview

11.13.3 Cepheid Emerging Infectious Disease Introduction

11.13.4 Cepheid Revenue in Emerging Infectious Disease Business (2020-2025)

11.13.5 Cepheid Recent Development

11.14 Hologic

11.14.1 Hologic Company Details

11.14.2 Hologic Business Overview

11.14.3 Hologic Emerging Infectious Disease Introduction

11.14.4 Hologic Revenue in Emerging Infectious Disease Business (2020-2025)

11.14.5 Hologic Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Biomerieux

Danaher

Orasure

Qiagen NV

Quidel

Sysmex

Gen-Probe

Cepheid Inc

Hologic Inc

Roche Diagnostics

Merck& Co. Inc

GlaxoSmithKline PLC

List of Tables

Table 1. Global Emerging Infectious Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of AIDS

Table 3. Key Players of Ebola

Table 4. Key Players of SARS

Table 5. Key Players of Avian Flu

Table 6. Key Players of Chikungunya

Table 7. Key Players of Zika

Table 8. Key Players of Others

Table 9. Global Emerging Infectious Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Emerging Infectious Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Emerging Infectious Disease Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Emerging Infectious Disease Market Share by Region (2020-2025)

Table 13. Global Emerging Infectious Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Emerging Infectious Disease Market Share by Region (2026-2031)

Table 15. Emerging Infectious Disease Market Trends

Table 16. Emerging Infectious Disease Market Drivers

Table 17. Emerging Infectious Disease Market Challenges

Table 18. Emerging Infectious Disease Market Restraints

Table 19. Global Emerging Infectious Disease Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Emerging Infectious Disease Market Share by Players (2020-2025)

Table 21. Global Top Emerging Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Infectious Disease as of 2024)

Table 22. Ranking of Global Top Emerging Infectious Disease Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Emerging Infectious Disease Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Emerging Infectious Disease, Headquarters and Area Served

Table 25. Global Key Players of Emerging Infectious Disease, Product and Application

Table 26. Global Key Players of Emerging Infectious Disease, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Emerging Infectious Disease Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Emerging Infectious Disease Revenue Market Share by Type (2020-2025)

Table 30. Global Emerging Infectious Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Emerging Infectious Disease Revenue Market Share by Type (2026-2031)

Table 32. Global Emerging Infectious Disease Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Emerging Infectious Disease Revenue Market Share by Application (2020-2025)

Table 34. Global Emerging Infectious Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Emerging Infectious Disease Revenue Market Share by Application (2026-2031)

Table 36. North America Emerging Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Emerging Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Emerging Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Emerging Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Emerging Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Emerging Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Emerging Infectious Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Emerging Infectious Disease Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Emerging Infectious Disease Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Emerging Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Emerging Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Emerging Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Emerging Infectious Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Emerging Infectious Disease Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Emerging Infectious Disease Market Size by Country (2026-2031) & (US$ Million)

Table 51. BD Company Details

Table 52. BD Business Overview

Table 53. BD Emerging Infectious Disease Product

Table 54. BD Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 55. BD Recent Development

Table 56. Abbott Company Details

Table 57. Abbott Business Overview

Table 58. Abbott Emerging Infectious Disease Product

Table 59. Abbott Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 60. Abbott Recent Development

Table 61. Roche Diagnostics Company Details

Table 62. Roche Diagnostics Business Overview

Table 63. Roche Diagnostics Emerging Infectious Disease Product

Table 64. Roche Diagnostics Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 65. Roche Diagnostics Recent Development

Table 66. Merck & Co., Inc. Company Details

Table 67. Merck & Co., Inc. Business Overview

Table 68. Merck & Co., Inc. Emerging Infectious Disease Product

Table 69. Merck & Co., Inc. Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 70. Merck & Co., Inc. Recent Development

Table 71. GlaxoSmithKline plc Company Details

Table 72. GlaxoSmithKline plc Business Overview

Table 73. GlaxoSmithKline plc Emerging Infectious Disease Product

Table 74. GlaxoSmithKline plc Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 75. GlaxoSmithKline plc Recent Development

Table 76. BioMerieux Company Details

Table 77. BioMerieux Business Overview

Table 78. BioMerieux Emerging Infectious Disease Product

Table 79. BioMerieux Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 80. BioMerieux Recent Development

Table 81. Danaher Company Details

Table 82. Danaher Business Overview

Table 83. Danaher Emerging Infectious Disease Product

Table 84. Danaher Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 85. Danaher Recent Development

Table 86. Orasure Company Details

Table 87. Orasure Business Overview

Table 88. Orasure Emerging Infectious Disease Product

Table 89. Orasure Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 90. Orasure Recent Development

Table 91. Qiagen Company Details

Table 92. Qiagen Business Overview

Table 93. Qiagen Emerging Infectious Disease Product

Table 94. Qiagen Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 95. Qiagen Recent Development

Table 96. Quidel Company Details

Table 97. Quidel Business Overview

Table 98. Quidel Emerging Infectious Disease Product

Table 99. Quidel Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 100. Quidel Recent Development

Table 101. Sysmex Company Details

Table 102. Sysmex Business Overview

Table 103. Sysmex Emerging Infectious Disease Product

Table 104. Sysmex Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 105. Sysmex Recent Development

Table 106. Gen-Probe Company Details

Table 107. Gen-Probe Business Overview

Table 108. Gen-Probe Emerging Infectious Disease Product

Table 109. Gen-Probe Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 110. Gen-Probe Recent Development

Table 111. Cepheid Company Details

Table 112. Cepheid Business Overview

Table 113. Cepheid Emerging Infectious Disease Product

Table 114. Cepheid Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 115. Cepheid Recent Development

Table 116. Hologic Company Details

Table 117. Hologic Business Overview

Table 118. Hologic Emerging Infectious Disease Product

Table 119. Hologic Revenue in Emerging Infectious Disease Business (2020-2025) & (US$ Million)

Table 120. Hologic Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Emerging Infectious Disease Picture

Figure 2. Global Emerging Infectious Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Emerging Infectious Disease Market Share by Type: 2024 VS 2031

Figure 4. AIDS Features

Figure 5. Ebola Features

Figure 6. SARS Features

Figure 7. Avian Flu Features

Figure 8. Chikungunya Features

Figure 9. Zika Features

Figure 10. Others Features

Figure 11. Global Emerging Infectious Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Emerging Infectious Disease Market Share by Application: 2024 VS 2031

Figure 13. Clinical Laboratories Case Studies

Figure 14. Diagnostic Centers Case Studies

Figure 15. Others Case Studies

Figure 16. Emerging Infectious Disease Report Years Considered

Figure 17. Global Emerging Infectious Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Emerging Infectious Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Emerging Infectious Disease Market Share by Region: 2024 VS 2031

Figure 20. Global Emerging Infectious Disease Market Share by Players in 2024

Figure 21. Global Top Emerging Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Infectious Disease as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Emerging Infectious Disease Revenue in 2024

Figure 23. North America Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Emerging Infectious Disease Market Share by Country (2020-2031)

Figure 25. United States Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Emerging Infectious Disease Market Share by Country (2020-2031)

Figure 29. Germany Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Emerging Infectious Disease Market Share by Region (2020-2031)

Figure 37. China Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Emerging Infectious Disease Market Share by Country (2020-2031)

Figure 45. Mexico Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Emerging Infectious Disease Market Share by Country (2020-2031)

Figure 49. Turkey Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Emerging Infectious Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. BD Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 53. Abbott Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 54. Roche Diagnostics Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 55. Merck & Co., Inc. Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 56. GlaxoSmithKline plc Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 57. BioMerieux Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 58. Danaher Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 59. Orasure Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 60. Qiagen Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 61. Quidel Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 62. Sysmex Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 63. Gen-Probe Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 64. Cepheid Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 65. Hologic Revenue Growth Rate in Emerging Infectious Disease Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Infectious Disease Diagnosis Market Insights Forecast to 2030

Global Infectious Disease Diagnostic Testing Kit Market Research Report 2024

Global Infectious Disease Testing And Diagnostic Market Research Report 2024

Global Veterinary Infectious Disease Diagnostics Market Insights Forecast to 2030

Global Infectious Disease Test Kit Market Research Report 2024

Communicable Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Travel Vaccines Market Insights Forecast to 2030

Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025

Healthcare associated Infectious Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Disease Drugs Market Insights Forecast to 2030

Infectious Immunology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Communicable Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Communicable Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Treatment for Communicable Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

STDs Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Vaccines Market Insights Forecast to 2030

Global Infectious Disease Clinical Trials Market Research Report 2025

Acquired Immunodeficiency Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions